Clinical Trial Update: Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 neoadjuvant trial update for HER2-positive early high-risk and locally advanced breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Invasive Breast Cancer

Snippet

Sponsor: Fondazione Michelangelo | Conditions: Invasive Breast Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING